TOP NEWS: Indivior swings to profit in 2021; mulling US listing
(Alliance News) - Indivior PLC shares jumped on Wednesday after it reported a swing to profit in 2021 and annual revenue moved closer to its eventual target of USD1 billion.
Read moreFri, 27th Nov 2020 11:44
(Alliance News) - Indivior PLC shares jumped on Wednesday after it reported a swing to profit in 2021 and annual revenue moved closer to its eventual target of USD1 billion.
Read more(Alliance News) - London's FTSE 100 stock index edged cautiously higher in early dealings on Wednesday, with a seeming de-escalation by Russia of its threat to Ukraine lifting the mood, though traders were wary about a backdrop of inflationary pressures in both the UK and US.
Read more(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.
Read more(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreUPDATE: Indivior notes robust results for treatment in fentanyl trial
Read moreCORRECT: Indivior notes results for painkiller in fentanyl trial
Read moreIndivior's painkiller demonstrates positive interaction with fentanyl
Read more(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.
Read moreEXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair
Read moreLONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data
Read moreIN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million
Read more(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.
Read moreLONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest
Read moreIndivior lifts 2021 revenue guidance amid strong Sublocade sales
Read more